Articles|  App notes / Features / Science success stories / Interviews / White papers

A unique approach to antibody production that exposes antibody candidates to nucleosomes is revolutionizing best practices.

Identifying novel biomarkers of Parkinson’s disease enables early diagnosis and treatment monitoring.

Cancer immunotherapy targets the tumor microenvironment, blocking the molecular pathways that tumors exploit to prevent immune cell activity.

Guidelines and built-in safeguards ensure the reproducibility of flow cytometry data.

Single-cell analysis provides a superior view of heterogeneous cell populations.

Scientists in cannabis extraction laboratories are bravely pioneering a new field of agro-chemical engineering.

Scientists uncover the promise of mesenchymal stem cells (MSCs), also known as medicinal signaling cells, to modulate the immune system and regenerate tissue.

A conversation with Dirk Ahlbrecht from Sartorius about where lab balance technology is headed in the 21st century

Cancer cells develop resistance to targeted therapies, and their inherent functional heterogeneity makes it difficult for researchers to understand and characterize these resistance mechanisms. IsoPlexis' single-cell proteomics is helping researchers overcome resistance to targeted inhibitors, leading to better strategies and combination therapies.

Scientists rely on synthetic biology and cell-free expression systems for developing novel approaches to combat the pandemic.

Arbor Biosciences is offering free SARS-CoV-2 myBaits kits to all researchers.  

Given its legal status as a controlled substance, researchers, producers, and developers still must be aware of a considerable number of regulatory guidelines and practices governing the cannabis industry.

Tully Stroud, Chief Scientific Officer for Elite Molecular Labs, talks about the growing field of cannabis extraction and refinement. 

Leonardo Ferreira, a postdoctoral fellow at the University of California, San Francisco, discusses the application of single cell proteomics data to understanding the function and therapeutic potential of genetically engineered regulatory T cells.

Vladimir Senyukov, Director of BioAnalytical Development at Precision Biosciences, talks about investigating T-cell cytokine production using single cell proteomics in order to unlock the therapeutic potential of allogeneic CAR-T cells.